Electromed, Inc. has announced the launch of its SmartVest Connect® App for iOS and Android, a personalized high-frequency chest wall oscillation (HFCWO) therapy management portal for patients with compromised pulmonary function. The SmartVest Connect app securely connects to the SmartVest® SQL® through Bluetooth™ technology. This interface allows patients and healthcare teams to […]
Tag: ELECTROMED
Vest Reduces Exacerbations, Antibiotic Use, and Stabilizes Lung Function as Part of a Treatment Algorithm
Electromed, Inc. has announced that a new, first-of-its-kind study published in BMC Pulmonary Medicine found that use of the SmartVest® Airway Clearance System as part of a treatment algorithm significantly decreased exacerbations requiring hospitalization and antibiotic use among non-CF bronchiectasis patients. The study also demonstrated stability of lung function post algorithm-based treatment, suggesting […]
Electromed Taps Industry Veteran for VP of Sales Role
Electromed, Inc. yesterday announced that Bud Reeves has joined the Company as Vice President of Sales and will oversee all domestic sales initiatives to accelerate revenue growth. Bud has over 20 years of sales and marketing leadership experience in the healthcare industry and brings a history of strong execution of […]
Independent Study: Bronchiectasis Exacerbations Reduced, Lung Function Stabilized with SmartVest®
Electromed, Inc. announced the results of an independent, outcome-based clinical study presented during the third annual World Bronchiectasis Conference in Washington D.C. The study’s findings reveal that early use of high-frequency chest wall oscillation (“HFCWO”) therapy with the SmartVest® Airway Clearance System significantly reduced severe exacerbations and hospitalizations among non-cystic […]
Electromed to Receive Refund for Medical Device Excise Taxes Paid
Electromed, Inc. maker of airway clearance technologies, announced that the Internal Revenue Service has agreed to refund the company approximately $406,000 related to federal medical device excise taxes paid on revenue associated with the sales of its SmartVest® Airway Clearance System during the company’s tax periods ended June 30, 2014 […]
Study Says: Bronchiectasis Exacerbations Significantly Reduced with HFCWO Therapy
Electromed, Inc. recently announced the results of a longitudinal outcome-based study published in Respiratory Therapy: The Journal of Pulmonary Technique. The longitudinal study shows that high-frequency chest wall oscillation (“HFCWO”) therapy with the SmartVest® Airway Clearance System significantly reduces bronchiectasis-related exacerbations including the need for antibiotics, emergency department visits, and […]









